Altimmune (ALT) EBIT Margin Growth (1y) (2011 - 2025)
Altimmune (ALT) EBIT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.62 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 9.96 Mn |
| Dec 31, 2024 | -40.64 Mn |
| Sep 30, 2024 | -48.91 Mn |
| Jun 30, 2024 | -23.48 Mn |
| Mar 31, 2024 | -43.23 Mn |
| Dec 31, 2023 | -204,990.00 |
| Sep 30, 2023 | 123.14 Mn |
| Jun 30, 2023 | -4.52 Mn |
| Mar 31, 2023 | -4.27 Mn |
| Dec 31, 2022 | -8.81 Mn |
| Sep 30, 2022 | -121.66 Mn |
| Jun 30, 2022 | -23.68 Mn |
| Mar 31, 2022 | -5.92 Mn |
| Dec 31, 2021 | -26,710.00 |
| Sep 30, 2021 | -2.04 Mn |
| Jun 30, 2021 | -1.78 Mn |
| Mar 31, 2021 | -144,317.00 |